Browsing: Beyond

Updated 2026/10/21 09:00 Professor Darren McGuire discusses the need for treatment strategies encompassing cardiovascular, kidney and metabolic diseases. / Photo = Health Chosun DB The treatment paradigm for diabetes is shifting from a focus on blood glucose levels toward integrated management encompassing cardiovascular, kidney and metabolic health. We spoke with experts from Korea and abroad…

Cold-water immersion is a popular post-workout recovery strategy, but new research suggests it may offer no greater benefit to muscle strength recovery than heat-based methods. The study, published in the Journal of Thermal Biology, investigated how different thermal recovery strategies affect muscle recovery following exercise-induced muscle damage

Formulators are moving toward botanicals like ashwagandha, bacopa, saffron, and PEA that target the stress, cortisol, and nervous-system pathways behind restless nights

Women’s telehealth platform Midi Health has unveiled a new brand identity as it expands beyond menopause care into a broader range of women’s health services

MOBILE, Ala. (WALA) – There’s more to recovery after breast cancer treatment than many people realize, and returning to exercise can be part of that journey

Movement beyond recovery: H2F aims to increase lethality with 5-domain approach to health, fitness

The gut does much more than digest food. It plays an important role in immunity, metabolism and overall health. As science unravels the complex world of the gut microbiome, its growing links to ageing, inflammation and cancer treatment are raising new questions about personalised healthcare. Yet, much of this emerging science is still evolving

Beyond 10,000 steps: Fitness wearables get smarter about recovery From watches and screenless bands that track heart rate variability, VO₂ max and sleep to physiological testing, fitness is moving beyond simply working out, but what consumers want to know is if all premium Representative image for fitness wearable Namrata Kohli7 min read Last Updated :…

This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people with diabetes and obesity

February 20, 2026 ByJoyce Hendley, Staff Writer